First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of
acquired autoimmune thrombophilia in which patients present with clinical features of …

Abstract Purpose of Review In recent years, the spectrum of neurological manifestations of
antiphospholipid syndrome (APS) has been growing. We provide a critical review of the …

Antiphospholipid syndrome (APS) is an autoimmune antibody-mediated condition
characterized by thrombotic events and/or pregnancy morbidity in association with persistent …

Immunologic and neuroinflammatory pathways have been found to play a major role in the
pathogenesis of many neurological disorders such as epilepsy, proposing the use of novel …

Antiphospholipid syndrome (APS) is a common autoimmune pro-thrombotic condition
characterised by thrombosis and pregnancy morbidity. There are a broad range of …

Abstract Purpose of the Review To review the available evidence on the management of a
variety of non-criteria manifestations in antiphospholipid syndrome (APS), including valvular …

Abstract Purpose of Review The purpose of this report is to review recent research findings
on APS in children and neonates. Recent Findings European evidence-based …

Abstract Purpose of Review Understanding of antiphospholipid antibody syndrome (APS),
associated neurological manifestations, and disease-directed treatment has grown …

Neuropsychiatric involvement in systemic lupus erythematosus (NPSLE) is a complex
condition that remains poorly understood, and includes heterogeneous manifestations …

Background Autoimmune epilepsy is a rarely diagnosed condition. Recognition of the
underlying autoimmune condition is important, as these patients can be resistant to …